# Amgen: portfolio, investments and team

> Amgen is a corporate vc based in United States. 45 investments on record, latest Mar 2019. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/amgen (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Amgen

Last cheque observed Mar 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Quiet Corporate VC

Series B Series C Series A Crowdfunding Finance Biotechnology

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 45 on record

Since the last cheque **2776** days **00** hrs **00** min **00** sec

Median round **$45M** Rounds led **1 of 45** Sole investor **4 rounds** Exits **4 from the portfolio** Mostly in **United States, 88%**

Pitch Amgen

## Amgen highlights

- 01 45 rounds on record
- 02 Mostly Series B and Series C: 61% of its rounds
- 03 Sole investor in 4 rounds, median $23M
- 04 4 exits from the portfolio

## What they do

- **Type:** Corporate VC (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** Crowdfunding Finance Biotechnology
- **Based in:** Thousand Oaks, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **45 appearances**

- **2019** 2 rounds
- **Mar** **[Imago BioSciences](https://millionrounds.com/company/imago-biosciences)** Series B · US · FinSMEs **$40M** With 6 others
- **Feb** **[Aetion](https://millionrounds.com/company/aetion)** Series B · US · FinSMEs **$27M** With 7 others
- **2018** 6 rounds
- **Nov** **[QurAlis](https://millionrounds.com/company/quralis)** Seed · US · FinSMEs **$5.5M** With 3 others
- **Oct** **[Oxford Nanopore Technologies](https://millionrounds.com/company/oxford-nanopore-technologies)** GB · Endpts **$66M** Sole investor
- **Jun** **[Precision](https://millionrounds.com/company/precision)** Series B · US · FinSMEs **$110M** With 18 others
- **Jun** **[Sutro](https://millionrounds.com/company/sutro)** Series E · US · FinSMEs **$85M** With 17 others
- **May** **[Akili](https://millionrounds.com/company/akili)** Series C · US · FinSMEs **$55M** With 4 others
- **Feb** **[Senti Biosciences](https://millionrounds.com/company/senti-biosciences)** Series A · US · FinSMEs **$53M** With 9 others
- **2017** 6 rounds
- **Dec** **[Obsidian Therapeutics](https://millionrounds.com/company/obsidian-therapeutics)** Series A · US · FinSMEs **$50M** With 5 others
- **Nov** **[Syapse](https://millionrounds.com/company/syapse)** Series D · US · FinSMEs **$30M** With 8 others
- **Oct** **[Kymera Therapeutics](https://millionrounds.com/company/kymera-therapeutics)** Series A · US · FinSMEs **$30M** With 1 other
- **Oct** **[Immatics](https://millionrounds.com/company/immatics)** Series E · DE · FinSMEs **$58M** With 3 others
- **Apr** **[Science 37](https://millionrounds.com/company/science-37)** Series C · US · FinSMEs **$29M** With 5 others
- **Jan** **[SiteOne Therapeutics](https://millionrounds.com/company/siteone-therapeutics)** Series B · US · Genengnews **$15M** *Led*
- **2013** 4 rounds
- **Dec** **[Sutro Biopharma](https://millionrounds.com/company/sutro-biopharma)** Series D · US · finsmes.com **$26M** With 5 others
- **Oct** **[Opsona](https://millionrounds.com/company/opsona)** Series C · IE · finsmes.com **$3.9M** With 8 others
- **Apr** **[Opsona](https://millionrounds.com/company/opsona)** Series C · IE · finsmes.com **$43M** With 7 others
- **Mar** **[Theraclone Sciences](https://millionrounds.com/company/theraclone-sciences)** Series B · US · finsmes.com **$8.0M** With 7 others
- **2012** 2 rounds
- **May** **[Sutro Biopharma](https://millionrounds.com/company/sutro-biopharma)** Series C · US · finance.yahoo.com **$17M** With 4 others
- **Apr** **[Miragen Therapeutics](https://millionrounds.com/company/miragen-therapeutics)** Series B · US · finsmes.com **$20M** With 4 others
- **2011** 3 rounds
- **Aug** **[Ardelyx](https://millionrounds.com/company/ardelyx)** Series B · US · ardelyx.com **$30M** With 2 others
- **Aug** **[Oncofactor Corporation](https://millionrounds.com/company/oncofactor-corporation)** Series A · US · onbiovc.com **$2.1M** With 5 others
- **Jan** **[Acylin Therapeutics](https://millionrounds.com/company/acylin-therapeutics)** Series A · US · onbiovc.com **$4.4M** With 3 others
- **2010** 5 rounds
- **Nov** **[Sutro Biopharma](https://millionrounds.com/company/sutro-biopharma)** Series C · US · finsmes.com **$37M** With 4 others
- **Sept** **[DecImmune Therapeutics](https://millionrounds.com/company/decimmune-therapeutics)** Venture · US · finsmes.com **$3.2M** With 2 others
- **Aug** **[TetraLogic Pharmaceuticals](https://millionrounds.com/company/tetralogic-pharmaceuticals)** Series C · US · fiercebiotech.com **$32M** With 7 others
- **Jun** **[Calistoga Pharmaceuticals](https://millionrounds.com/company/calistoga-pharmaceuticals)** Series C · US · calistogapharma.com **$40M** With 5 others
- **Mar** **[Theraclone Sciences](https://millionrounds.com/company/theraclone-sciences)** Series B · US · xconomy.com **$1.5M** With 5 others
- **2009** 4 rounds
- **Nov** **[Trinity Biosystems](https://millionrounds.com/company/trinity-biosystems)** Debt · US · deals.venturebeat.com **$7.5M** With 4 others
- **Oct** **[Epizyme](https://millionrounds.com/company/epizyme)** Series B · US · fiercebiotech.com **$32M** With 4 others
- **Jun** **[Miragen Therapeutics](https://millionrounds.com/company/miragen-therapeutics)** Series B · US · biospace.com **$4.0M** With 3 others
- **May** **[Calistoga Pharmaceuticals](https://millionrounds.com/company/calistoga-pharmaceuticals)** Series B · US **$30M** With 3 others
- **2008** 1 round
- **Aug** **[InteKrin](https://millionrounds.com/company/intekrin)** Series C · US · deals.venturebeat.com **$19M** With 6 others
- **2007** 3 rounds
- **Oct** **[Allozyne](https://millionrounds.com/company/allozyne)** Series B · US · allbusiness.com **$30M** With 4 others
- **Jun** **[Cutting Edge Information](https://millionrounds.com/company/cutting-edge-information)** Series A · US · salesandmarketingnetwork.com **$16M** With 2 others
- **Mar** **[Calistoga Pharmaceuticals](https://millionrounds.com/company/calistoga-pharmaceuticals)** Series A · US · calistogapharma.com **$21M** With 3 others
- **2006** 4 rounds
- **Jul** **[Trinity Biosystems](https://millionrounds.com/company/trinity-biosystems)** Series B · US **$21M** With 3 others
- **Jun** **[VLST Corporation](https://millionrounds.com/company/vlst-corporation)** Series B · US · vlstcorp.com **$55M** With 6 others
- **May** **[Viron Therapeutics](https://millionrounds.com/company/viron-therapeutics)** Series A · CA · vironinc.com **$20M** With 5 others
- **May** **[Avidia](https://millionrounds.com/company/avidia)** Series C · US · freshnews.com **$44M** With 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **48** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**5+** funds on file numbered funds in its name

## Exits from the portfolio

Companies it backed that were later bought or listed **4 in all**

**[PTC Therapeutics](https://millionrounds.com/company/ptc-therapeutics)** Listed **$125M** Jun 2013

**[Epizyme](https://millionrounds.com/company/epizyme)** Listed **$60M** May 2013

**[Calistoga Pharmaceuticals](https://millionrounds.com/company/calistoga-pharmaceuticals)** Bought by [Gilead Sciences](https://millionrounds.com/fund/gilead-sciences) **$375M** Feb 2011

**[Avidia](https://millionrounds.com/company/avidia)** Bought by [Amgen](https://millionrounds.com/fund/amgen) **$290M** Sept 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

## Companies it bought

Acquisitions by the firm itself

**[Dezima Pharma](https://millionrounds.com/company/dezima-pharma)** **$300M** Sept 2015

**Onyx Pharmaceuticals** **$11B** Aug 2013

**[KAI Pharmaceuticals](https://millionrounds.com/company/kai-pharmaceuticals)** **$315M** Apr 2012

**Micromet** **$1.2M** Jan 2012

**[BioVex](https://millionrounds.com/company/biovex)** **$1.0B** Jan 2011

**[Avidia](https://millionrounds.com/company/avidia)** **$290M** Sept 2008

**[Alantos Pharmaceuticals](https://millionrounds.com/company/alantos-pharmaceuticals)** **Undisclosed** Jun 2007

**Ilypsa** **$420M** Jun 2007

## The cheque

Series B Series C Series A

Median round joined **$45M** the round, not its cheque Alone, median **$23M**

Led 1 of 45 rounds **2%**

- **Sole investor:** 4 rounds
- **Last cheque:** Mar 2019
- **Exits:** 4 from the portfolio

Rounds by stage said on their site

- Series B *15*
- Series C *10*
- Series A *9*
- Venture *3*
- Series D *2*
- Series E *2*

Cheques by year Led Joined

2004 2019

Often in the room with

- [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) 7
- [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) 7
- [Alta Partners](https://millionrounds.com/fund/alta-partners) 6
- [MPM Capital](https://millionrounds.com/fund/mpm-bioimpact) 6
- [HealthCare Ventures](https://millionrounds.com/fund/healthcare-ventures-llc) 5
- [OVP Venture Partners](https://millionrounds.com/fund/ovp-venture-partners) 5

**Pitching Amgen?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Amgen. A count of rooms they were both in, not a relationship either has claimed.

[**ARCH Venture Partners** VC firm **7** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**Alexandria Real Estate Equities** VC firm **7** rounds together](https://millionrounds.com/fund/alexandria)[**Alta Partners** VC firm **6** rounds together](https://millionrounds.com/fund/alta-partners)[**MPM Capital** Private equity **6** rounds together](https://millionrounds.com/fund/mpm-bioimpact)[**HealthCare Ventures** Growth equity **5** rounds together](https://millionrounds.com/fund/healthcare-ventures-llc)[**OVP Venture Partners** VC firm **5** rounds together](https://millionrounds.com/fund/ovp-venture-partners)[**Skyline Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/skyline-ventures)[**Frazier Healthcare Partners** Private equity **4** rounds together](https://millionrounds.com/fund/frazier-healthcare-partners)[**Novartis Venture Fund** Corporate VC **4** rounds together](https://millionrounds.com/fund/novartis-venture-fund)[**Lilly Ventures** Corporate VC **3** rounds together](https://millionrounds.com/fund/lilly-ventures)[**MedImmune Ventures** Corporate VC **3** rounds together](https://millionrounds.com/fund/medimmune-ventures)[**SV Life Sciences** VC firm **3** rounds together](https://millionrounds.com/fund/sv-life-sciences)

## Recently backed

The latest companies Amgen put money into.

[**Aetion** $27M · Feb 2019](https://millionrounds.com/company/aetion)[**QurAlis** $5.5M · Nov 2018](https://millionrounds.com/company/quralis)[**Oxford Nanopore Technologies** $66M · Oct 2018](https://millionrounds.com/company/oxford-nanopore-technologies)[**Akili** $55M · May 2018](https://millionrounds.com/company/akili)[**Senti Biosciences** $53M · Feb 2018](https://millionrounds.com/company/senti-biosciences)[**Obsidian Therapeutics** $50M · Dec 2017](https://millionrounds.com/company/obsidian-therapeutics)

## Quick answers about Amgen

### What does Amgen invest in?

Amgen invests most often at Series B and Series C (61% of the rounds on record), in sectors such as Crowdfunding, Finance and Biotechnology.

### How active is Amgen?

45 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in Mar 2019.

### What has Amgen invested in recently?

Its most recent investments on record: Imago BioSciences (Series B, Mar 2019), Aetion (Series B, Feb 2019) and QurAlis (Seed, Nov 2018).

### How big are Amgen's cheques?

The median round it joins is $45M.

### Does Amgen lead rounds?

Sometimes: it led 1 of its 45 investments on record (2%).

### Where does Amgen invest?

Most of the companies it backs are in the United States (88%) and Ireland (5%).

### Is Amgen investing now?

No investments in the last 12 months; the latest was in Mar 2019.

### Who does Amgen invest alongside?

Most often ARCH Venture Partners (7 rounds together), Alexandria Real Estate Equities (7 rounds together) and Alta Partners (6 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=amgen) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=amgen)